Hypothesis

14 Matching Annotations

Last 7 days
www.sciencedirect.com www.sciencedirect.com

Biomarker study of pembrolizumab in patients with advanced rare cancers

1
1. scibot 17 Jun 2026
  
  in Public
  
  RRID:AB_2631307
  
  DOI: 10.1016/j.xcrm.2026.102827
  
  Resource: (Agilent Cat# M351501-2, RRID:AB_2631307)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2631307
  
  What is this?
  
  RRID:AB_2631307
Visit annotations in context

Tags

RRID:AB_2631307

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666379126002442
May 2025
www.sciencedirect.com www.sciencedirect.com

Tumor immune microenvironment delineates progression trajectories of distinct nasopharyngeal carcinoma phenotypes

1
1. scibot 29 May 2025
  
  in Public
  
  RRID:AB_2631307
  
  DOI: 10.1016/j.xcrm.2025.102143
  
  Resource: (Agilent Cat# M351501-2, RRID:AB_2631307)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2631307
  
  What is this?
  
  RRID:AB_2631307
Visit annotations in context

Tags

RRID:AB_2631307

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666379125002162
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

Phase II Trial of Atezolizumab and Bevacizumab for Treatment of HPV-Positive Unresectable or Metastatic Squamous Cell Carcinoma of the Anal Canal

1
1. scibot 20 May 2025
  
  in Public
  
  RRID:AB_2631307
  
  DOI: 10.1158/1078-0432.CCR-24-1512
  
  Resource: (Agilent Cat# M351501-2, RRID:AB_2631307)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2631307
  
  What is this?
  
  RRID:AB_2631307
Visit annotations in context

Tags

RRID:AB_2631307

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC12010964/
Mar 2025
52.53.155.43 52.53.155.43

PDF-html.html

1
1. scibot 05 Mar 2025
  
  in Public
  
  RRID:AB_2631307
  
  DOI: 10.1158/1078-0432.ccr-24-1512
  
  Resource: (Agilent Cat# M351501-2, RRID:AB_2631307)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2631307
  
  What is this?
  
  RRID:AB_2631307
Visit annotations in context

Tags

RRID:AB_2631307

Annotators

scibot

URL

52.53.155.43/bd54bfc20a8f6423db7f5fe71487b5cd257ee354/PDF-html.html
Nov 2024
www.sciencedirect.com www.sciencedirect.com

Multi-platform biomarkers of response to an immune checkpoint inhibitor in the neoadjuvant I-SPY 2 trial for early-stage breast cancer

1
1. scibot 16 Nov 2024
  
  in Public
  
  RRID:AB_2631307
  
  DOI: 10.1016/j.xcrm.2024.101799
  
  Resource: (Agilent Cat# M351501-2, RRID:AB_2631307)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2631307
  
  What is this?
  
  RRID:AB_2631307
Visit annotations in context

Tags

RRID:AB_2631307

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666379124005469
Sep 2024
www.sciencedirect.com www.sciencedirect.com

Distinct tumor architectures and microenvironments for the initiation of breast cancer metastasis in the brain

1
1. scibot 13 Sep 2024
  
  in Public
  
  AB_2631307
  
  DOI: 10.1016/j.ccell.2024.08.015
  
  Resource: (Agilent Cat# M351501-2, RRID:AB_2631307)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2631307
  
  What is this?
  
  RRID:AB_2631307
Visit annotations in context

Tags

RRID:AB_2631307

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1535610824003143
Aug 2024
www.sciencedirect.com www.sciencedirect.com

Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer: Clinical and translational results from a phase 2 trial

1
1. scibot 22 Aug 2024
  
  in Public
  
  RRID:AB_2631307
  
  DOI: 10.1016/j.medj.2024.07.022
  
  Resource: (Agilent Cat# M351501-2, RRID:AB_2631307)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2631307
  
  What is this?
  
  RRID:AB_2631307
Visit annotations in context

Tags

RRID:AB_2631307

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666634024003039
Feb 2024
www.sciencedirect.com www.sciencedirect.com

Characterization of the human fetal gonad and reproductive tract by single-cell transcriptomics

1
1. scibot 02 Feb 2024
  
  in Public
  
  RRID:AB_2631307
  
  DOI: 10.1016/j.devcel.2024.01.006
  
  Resource: (Agilent Cat# M351501-2, RRID:AB_2631307)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2631307
  
  What is this?
  
  RRID:AB_2631307
Visit annotations in context

Tags

RRID:AB_2631307

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1534580724000066
Nov 2023
www.sciencedirect.com www.sciencedirect.com

Th1/17 polarization and potential treatment by an anti-interferon-γ DNA aptamer in Hunner-type interstitial cystitis

1
1. scibot 29 Nov 2023
  
  in Public
  
  RRID:AB_2631307
  
  DOI: 10.1016/j.isci.2023.108262
  
  Resource: (Agilent Cat# M351501-2, RRID:AB_2631307)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2631307
  
  What is this?
  
  RRID:AB_2631307
Visit annotations in context

Tags

RRID:AB_2631307

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2589004223023398
Oct 2023
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

Single-Cell Characterization of Pulmonary Nodules Implicates Suppression of Immunosurveillance across Early Stages of Lung Adenocarcinoma

1
1. scibot 06 Oct 2023
  
  in Public
  
  RRID:AB_2631307
  
  DOI: 10.1158/0008-5472.CAN-23-0128
  
  Resource: (Agilent Cat# M351501-2, RRID:AB_2631307)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2631307
  
  What is this?
  
  RRID:AB_2631307
Visit annotations in context

Tags

RRID:AB_2631307

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC10544016/
Nov 2022
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

NF-κB-regulated VentX expression mediates tumoricidal effects of chemotherapeutics at noncytotoxic concentrations

1
1. scibot 18 Nov 2022
  
  in Public
  
  RRID:AB_2631307
  
  DOI: 10.1016/j.isci.2022.105426
  
  Resource: (Agilent Cat# M351501-2, RRID:AB_2631307)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2631307
  
  What is this?
  
  RRID:AB_2631307
Visit annotations in context

Tags

RRID:AB_2631307

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC9641229/
Jul 2021
www.sciencedirect.com www.sciencedirect.com

Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STING

1
1. scibot 23 Jul 2021
  
  in Public
  
  RRID:AB_2631307
  
  DOI: 10.1016/j.celrep.2021.109412
  
  Resource: (Agilent Cat# M351501-2, RRID:AB_2631307)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2631307
  
  What is this?
  
  RRID:AB_2631307
Visit annotations in context

Tags

RRID:AB_2631307

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2211124721008251
Nov 2018
www.sciencedirect.com www.sciencedirect.com

Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny

1
1. scibot 05 Nov 2018
  
  in Public
  
  RRID:AB_2631307
  
  Resource used:
  
  (Dako Cat# M351501-2, RRID:AB_2631307)
  
  SciCrunch record: RRID:AB_2631307
  
  Alternate resolvers: SciCrunch xml N2T identifiers.org
  
  What is this?
  
  RRID:AB_2631307
Visit annotations in context

Tags

RRID:AB_2631307

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S221112471831492X
Nov 2017
www.sciencedirect.com www.sciencedirect.com

Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling

1
1. scibot 08 Nov 2017
  
  in Public
  
  RRID:AB_2631307
  
  Curator: @Jmenke
  
  Resource used:
  
  (Dako Cat# M351501-2, RRID:AB_2631307)
  
  SciCrunch record: RRID:AB_2631307
  
  Alternate resolvers: SciCrunch xml N2T identifiers.org
  
  What is this?
  
  RRID:AB_2631307 RRIDCUR:Validated
Visit annotations in context

Tags

RRIDCUR:Validated

RRID:AB_2631307

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1535610817304075